List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 82 studies with search of: prostate cancer, vaccine therapy
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Flutamide With or Without Vaccine Therapy in Treating Patients With Nonmetastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: recombinant fowlpox-prostate apecific antigen vaccine;   Biological: recombinant vaccinia prostate-specific antigen vaccine;   Biological: sargramostim;   Drug: flutamide
2 Completed Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: recombinant viral vaccine therapy;   Biological: sargramostim
3 Not yet recruiting Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: GVAX prostate cancer vaccine;   Drug: bicalutamide;   Drug: goserelin;   Drug: leuprolide acetate
4 Active, not recruiting Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: prostatic acid phosphatase-sargramostim fusion protein;   Biological: sipuleucel-T;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
5 Active, not recruiting Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: MUC-2-Globo H-KLH conjugate vaccine;   Biological: QS21
6 Completed Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: recombinant fowlpox-prostate apecific antigen vaccine;   Biological: recombinant vaccinia prostate-specific antigen vaccine;   Biological: recombinant vaccinia-B7.1 vaccine;   Biological: sargramostim;   Drug: docetaxel
7 Active, not recruiting Vaccine Therapy With or Without Sargramostim in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: fowlpox-PSA-TRICOM vaccine;   Biological: recombinant fowlpox GM-CSF vaccine adjuvant;   Biological: sargramostim;   Biological: vaccinia-PSA-TRICOM vaccine
8 Active, not recruiting Vaccine Therapy, MDX-010, and GM-CSF in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: fowlpox-PSA-TRICOM vaccine;   Biological: ipilimumab;   Biological: sargramostim;   Biological: vaccinia-PSA-TRICOM vaccine
9 Active, not recruiting Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH conjugate vaccine;   Biological: QS21
10 Active, not recruiting Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
Condition: Prostate Cancer
Interventions: Biological: fowlpox-PSA-TRICOM vaccine;   Biological: sargramostim;   Biological: vaccinia-PSA-TRICOM vaccine;   Drug: bicalutamide;   Drug: goserelin
11 Completed Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: GPI-0100;   Biological: MUC-2-Globo H-KLH conjugate vaccine
12 Completed Radiation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: aldesleukin;   Biological: recombinant fowlpox-prostate apecific antigen vaccine;   Biological: recombinant vaccinia prostate-specific antigen vaccine;   Biological: recombinant vaccinia-B7.1 vaccine;   Biological: sargramostim;   Radiation: brachytherapy;   Radiation: radiation therapy
13 Active, not recruiting Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: PSA prostate cancer vaccine;   Biological: recombinant interleukin-12
14 Active, not recruiting Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel
Condition: Prostate Cancer
Intervention: Biological: rsPSMA protein plus Alhydrogel® vaccine
15 Recruiting Samarium Sm 153 Lexidronam Pentasodium With or Without Vaccine Therapy in Treating Patients With Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer;   Pain;   Prostate Cancer
Interventions: Biological: recombinant fowlpox-TRICOM vaccine;   Biological: recombinant vaccinia-TRICOM vaccine;   Biological: sargramostim;   Radiation: samarium Sm 153 lexidronam pentasodium
16 Active, not recruiting Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: PSA prostate cancer vaccine;   Biological: incomplete Freund's adjuvant
17 Active, not recruiting Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: BCG vaccine;   Biological: prostate cancer vaccine ONY-P1;   Other: placebo
18 Active, not recruiting Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: Prostate Cancer
Interventions: Biological: PSA prostate cancer vaccine;   Biological: therapeutic autologous dendritic cells
19 Completed Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: QS21;   Biological: TF(c)-KLH conjugate vaccine;   Biological: Thomsen-Friedenreich antigen;   Biological: keyhole limpet hemocyanin
20 Recruiting Vaccine Therapy in Treating Patients With Progressive Stage D0 Prostate Cancer
Condition: Prostate Cancer
Interventions: Biological: TARP 27-35 peptide vaccine;   Biological: TARP 29-37-9V peptide vaccine;   Biological: autologous TARP peptide-pulsed dendritic cell vaccine;   Biological: incomplete Freund's adjuvant;   Biological: sargramostim

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services